Melatonin a Promising Candidate for DNA Double-Stranded Breaks Reduction in Patients Undergoing Abdomen-Pelvis Computed Tomography Examinations

Anticancer Agents Med Chem. 2020;20(7):859-864. doi: 10.2174/1871521409666200324101701.

Abstract

Background and objective: Cancer incidence is 24% higher in children and young adults exposed to Computed Tomography (CT) scans than those unexposed. Non-repairing of ionizing radiation-induced DNA Double-Strand Breaks (DSBs) can initiate carcinogenesis. In the present study, we aimed to investigate the radioprotective potential of melatonin against DSBs in peripheral blood lymphocytes of patients undergoing abdomen-pelvis CT examinations.

Methods: This double-blind, placebo-controlled clinical trial was conducted on thirty patients. These patients were divided into two groups; group one (control) patients who have undergone the CT examination received a single oral dose of placebo, while in group two, patients received a single oral dose of 100mg melatonin. In both the groups, blood samples were collected 5-10min before and 30 minutes after the CT examination. The lymphocytes from these samples were isolated and DSBs were analyzed using γH2AX immunofluorescence microscopy.

Results: Compared to the control group, the use of melatonin 1h before the CT examination caused a significant reduction in γH2AX-foci, indicating a reduction in DSBs. In addition, no side effect was observed in patients following 100mg melatonin administration.

Conclusion: For the first time, this study has shown that melatonin has protective effects against radiationinduced genotoxicity in peripheral blood lymphocytes of patients undergoing abdomen-pelvis CT examinations. Therefore, melatonin can be considered as a promising candidate for reducing DSBs in patients undergoing abdomen-pelvis CT examinations.

Keywords: DSB; Melatonin; computed tomography; lymphocytes; radiation; γH2AX.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Abdomen / diagnostic imaging*
  • Administration, Oral
  • Adolescent
  • Adult
  • DNA Breaks, Double-Stranded / drug effects
  • Double-Blind Method
  • Humans
  • Male
  • Melatonin / administration & dosage
  • Melatonin / pharmacology*
  • Middle Aged
  • Pelvis / diagnostic imaging*
  • Protective Agents / administration & dosage
  • Protective Agents / pharmacology*
  • Tomography, X-Ray Computed*
  • Young Adult

Substances

  • Protective Agents
  • Melatonin